HLA alleles in pre-menopausal breast cancer patients from western India

Indian Journal of Medical Research

Volumn 124, Issue 3, 2006, Pages 305-312

  Gopalkrishnan, L ^a   Patil, S ^a   Chhaya, S ^a,b   Badwe, R ^a   Joshi, N ^a  

^a TATA MEMORIAL HOSPITAL   (India)

^b RELIANCE LIFE SCIENCES PVT LTD   (India)

Author keywords

Breast cancer; Haplotype frequencies; HLA B* 40; HLA class I allele; Linkage disequilibrium

Indexed keywords

HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA B40 ANTIGEN; HLA B8 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CELLULAR IMMUNITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOTOXICITY; DISEASE ASSOCIATION; DNA EXTRACTION; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENOTYPE; HAPLOTYPE; HLA TYPING; HOMOZYGOSITY; HUMAN; IMMUNE RESPONSE; IMMUNOGENETICS; IMMUNOMODULATION; IMMUNOSURVEILLANCE; INDIA; INNATE IMMUNITY; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; POLYMERASE CHAIN REACTION; PREMENOPAUSE;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENES, MHC CLASS I; GENOTYPE; HETEROZYGOTE DETECTION; HUMANS; INDIA; PREMENOPAUSE; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 33750936387     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bateman AC, Howell WM. Human leukocyte antigens and cancer: Is it in your genes? J Pathol 1999; 188 : 231-6.
2. Lynch H, Thomas RJ, Terasaki PI, Ting A, Guirgis H, Kaplan AR, et al. HL-A in cancer family "N". Cancer 1975; 36 : 1315-20.
3. Sivak ML Jr, Sivak D, Braun WA, Sullivan BH. A linkage study of HLA and inherited adenocarcinoma of the colon. Cancer 1981; 48 : 76-81.
4. Ljunggren HG, Karre K. In search of the 'missing self'. MHC molecules and NK cell recognition. Immunol Today 1990; 11 : 237-44.
5. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002; 20 : 217-51.
6. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nature Rev Immunol 2005; 5 : 201-14.
7. Dubey DP, Alper CA, Mirza NM, Awdeh Z, Yunis EJ. Polymorphic Hh genes in the HLA - B(C) region control natural killer cell frequency and activity. J Exp Med 1993; 179 : 1193-203.
8. Wallace DM. General methods for isolating and characterizing nucelic acids : Large- and small-scale phenol extractions. Methods Enzymol 1987; 152 : 33-41.
9. Helmberg W, Lanzer G, Zahn R, Weinmayr B, Wagner T, Albert E. Virtual DNA analysis - a new tool for combination and standardised evaluation of SSO, SSP and sequencing-based typing results. Tissue Antigens 1998; 51 : 587-92.
10. Schneider S, Roessli D, Excoffier L. Arlequin. ver. 2.000: A software for population genetics data analysis. 2000. Genetics and Biometry Lab, Department of Anthropology, University of Geneva, Geneva.
11. Yeh FC, Yang R, Boyle T. Popgene. Version 1.31. 1999. University of Alberta, Canada.
12. Haldane JBS. The estimation and significance of the logarithm of the ratio of frequencies. Ann Hum Gent 1955; 20 : 309-14.
13. Dewey ME, Bonferroni CE. In: Armitage P, Colton T, editors. Encyclopaedia of biostatistics. Wiley, Chichester; 1998 p. 420-1.
14. Svejgaard A, Ryder LP. HLA and disease associations: Detecting the strongest association. Tissue Antigens 1994; 43 : 18-27.
15. Mattiuz PL, Ihde D, Piazza A, Cepellini R, Bodmer WF. New approaches to the population genetic and segregation analysis of the HL-A system. In: Terasaki P, editor. Histocompatibility testing 1970. Copenhagen: Munksgaard; 1971 p. 193-205.
16. Shankarkumar U, Ghosh K, Mohanty D. HLA class I antigen profile among Brahmins and related caste groups from Mumbai, Maharashtra, India. Indian J Hum Genet 2000; 6 : 21-8.
17. Shankarkumar U, Ghosh K, Mohanty D. HLA antigen distribution in Maratha community from Mumbai, Maharashtra, India. Int J Hum Genet 2001; 1 : 173-7.
18. Chaudhuri S, Cariappa A, Tang M, Bell D, Haber DA, Isselbacher KJ, et al. Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles. Proc Natl Acad Sci USA 2000; 97 : 11451-4.
19. Bouillenne C, Deneufbourg JM. Positive correlation between breast cancer incidence and HLA antigens. Oncology 1979; 36 : 156-9.
20. Biswal BM, Kumar R, Julka PK, Sharma U, Vaidya MC. Human leucocytic antigens (HLA) in breast cancer. Indian J Med Sci 1998; 52 : 177-83.
21. Bagwe A, Shah B, Bhalavat R, Naik SN, Undevia JV. HLA antigens in cancer of the uterine cervix in Western India. Indian J Hematol Blood Transf 1991; 9 : 21-4.
22. Shankarkumar U, Prasanavar D, Gosh K, Mohanty D. HLA A*02 allele frequencies and B haplotype associations in western Indians. Human Immunol 2003; 64 : 562-6.
23. Papadopoulos KP, Hesdorffer CS, Suciu-Foca N, Hibshoosh H, Harris PE. Wild-type p53 epitope naturally processed and presented by an HLA-B haplotype on human breast carcinoma cells. Clin Cancer Res 1999; 5 : 2089-93.
24. Zhang C, Anderson A, DeLisi C. Structural principles that govern the peptide-binding motifs of class I MHC molecules. J Mol Biol 1998; 281 : 929-47.
25. Sidney J, Southwood S, Pasquetto V, Sette A. Simultaneous prediction of binding capacity for multiple molecules of the HLA B44 supertype. J Immunol 2003; 171 : 5964-74.
26. Falk K, Rotzschke O, Takiguchi M, Gnau V, Stevanovic S, Jung G, et al. Peptide motifs of HLA-B58, B60, B61, and B62 molecules. Immunogenetics 1995; 41 : 165-8.
27. Schultz ES, Chapiro J, Lurquin C, Claverol S, Burlet-Schiltz O, Warnier G, et al. The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome. J Exp Med 2002; 195 : 391-9.
28. Ellis JR, Keating PJ, Baird J, Hounsell EF, Renouf DV, Rowe M, et al. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat Med 1995: 1 : 464-70.
29. Long EO. Tumor cell recognition by natural killer cells. Semin Cancer Biol 2002; 12 : 57-61.